Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

Clinical trial NCT04538625 · COMPLETED

Trial details

NCT number: NCT04538625
Sponsor: Napo Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Therapy-Related Diarrhea Chemotherapy-related Diarrhea Adult Solid Tumor Prophylaxis of Diarrhea Symptomatic Relief of Diarrhea Targeted Therapy-related Diarrhea

Start date: 2020-10-07
Primary completion: 2023-08-07
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.